UK based Cobra Biomanufacturing has appointed Dr John Lovelady as Director of Manufacturing Operations for the Group. John replaces Dr Martin Comberbach who will be retained by the Company as a consultant.

John was previously Vice President of Technical R&D and Manufacturing at  Gencell SA, Paris and prior to that as Vice President Operations at Genzyme Corporation UK.

David Thatcher, Chief Executive of Cobra Biomanufacturing, commented: “We are delighted that John Lovelady has joined Cobra to further strengthen our GMP production services. His unique blend of skill and experience will greatly enhance the quality and efficiency of our manufacturing services. ”